We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$21.2B
AUM Growth
+$2.31B
Cap. Flow
+$622M
Cap. Flow %
2.93%
Top 10 Hldgs %
15.94%
Holding
1,089
New
178
Increased
395
Reduced
238
Closed
219

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$215M
2
T icon
AT&T
T
+$206M
3
KEYS icon
Keysight
KEYS
+$199M
4
AMZN icon
Amazon
AMZN
+$154M
5
NXPI icon
NXP Semiconductors
NXPI
+$149M

Sector Composition

Rank Sector Weight
1 Technology 25.42%
2 Healthcare 23.84%
3 Financials 10.35%
4 Consumer Discretionary 9.93%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEM
501
DELISTED
Select Medical
SEM
$7.16M 0.03%
+557,592
New +$7.43M
AFL icon
502
Aflac
AFL
$64.5B
$7.11M 0.03%
63,620
+32,783
+106% +$3.44M
VLO icon
503
Valero Energy
VLO
$87.2B
$6.99M 0.03%
41,057
+7,178
+21% +$1.07M
ALMS
504
Alumis Inc
ALMS
$3.54B
$6.99M 0.03%
1,751,150
+1,558,660
+810% +$6.42M
D icon
505
Dominion Energy
D
$58.8B
$6.9M 0.03%
112,791
+20,546
+22% +$1.22M
SLB icon
506
SLB Ltd
SLB
$76.5B
$6.78M 0.03%
197,180
+50,054
+34% +$1.74M
IDXX icon
507
Idexx Laboratories
IDXX
$46.5B
$6.76M 0.03%
10,574
+1,875
+22% +$1.14M
ZLAB icon
508
Zai Lab
ZLAB
$2.34B
$6.73M 0.03%
198,509
-1,002,507
-83% -$34.5M
LEGN icon
509
Legend Biotech
LEGN
$3.73B
$6.69M 0.03%
205,077
PLRX icon
510
Pliant Therapeutics
PLRX
$65M
$6.67M 0.03%
4,504,817
+2,156,291
+92% +$3.29M
ROST icon
511
Ross Stores
ROST
$81.6B
$6.59M 0.03%
43,227
+7,658
+22% +$1.09M
MCK icon
512
McKesson
MCK
$102B
$6.52M 0.03%
+8,438
New +$5.94M
LITE icon
513
Lumentum
LITE
$65.2B
$6.5M 0.03%
+39,950
New +$4.98M
PTCT icon
514
PTC Therapeutics
PTCT
$5.91B
$6.48M 0.03%
+105,605
New +$5.5M
CENX icon
515
Century Aluminum
CENX
$4.55B
$6.47M 0.03%
220,264
-1,069,227
-83% -$24.2M
CAVA icon
516
CAVA Group
CAVA
$7.25B
$6.42M 0.03%
106,220
-87,826
-45% -$6.65M
INDV icon
517
Indivior Pharmaceuticals
INDV
$4.56B
$6.41M 0.03%
+265,998
New +$5.57M
MRNA icon
518
Moderna
MRNA
$21.5B
$6.4M 0.03%
247,773
+800
+0.3% +$22.3K
BKR icon
519
Baker Hughes
BKR
$62.3B
$6.35M 0.03%
130,296
+23,128
+22% +$1.02M
EMPD
520
Empery Digital
EMPD
$79.6M
$6.35M 0.03%
+843,767
New +$7.62M
XEL icon
521
Xcel Energy
XEL
$48.1B
$6.3M 0.03%
78,162
+15,775
+25% +$1.14M
AWI icon
522
Armstrong World Industries
AWI
$7.78B
$6.23M 0.03%
31,771
-66,453
-68% -$12.4M
EMR icon
523
Emerson Electric
EMR
$87.5B
$6.21M 0.03%
47,341
-376
-0.8% -$51.3K
HBM icon
524
Hudbay
HBM
$11.7B
$6.16M 0.03%
406,370
-2,656,925
-87% -$30.4M
ELVN icon
525
Enliven Therapeutics
ELVN
$4.42B
$6.15M 0.03%
300,499
-800,158
-73% -$16.1M

Similar funds

Woodline Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Woodline Partners held 1,089 positions worth $21.2B, up 12% from $18.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners's Q3 2025 filing shows 178 new, 395 increased, 238 reduced and 219 closed positions. Its largest new stake was Chubb: 780,221 shares worth $220M. The largest sale was Meta Platforms (Facebook), an estimated $224M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Woodline Partners's largest Q3 2025 buy was Chubb: 780,221 shares worth $220M.
  • Woodline Partners added most to AT&T in Q3 2025, an estimated $206M increase.
  • Woodline Partners's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $224M.
  • Woodline Partners fully exited Brown & Brown in Q3 2025, selling an estimated $120M.
  • Woodline Partners's ten largest holdings make up 16% of its $21.2B portfolio in Q3 2025.
  • Woodline Partners opened 178 new positions and closed 219 in Q3 2025.
  • Woodline Partners's portfolio value rose 12% quarter-over-quarter to $21.2B.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.